These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 5403803)

  • 41. [Radiological evaluation of the state of hydration in uremic patients under periodic dialysis].
    Gavelli G; Zompatori M; Bernasconi A; Baldrati L; Buscaroli A; Orsi C
    Radiol Med; 1984 Dec; 70(12):933-6. PubMed ID: 6545610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hemodialysis and social recovery of chronic uremic patients].
    Cortesini R
    Minerva Nefrol; 1967; 14(4):193-5. PubMed ID: 5607561
    [No Abstract]   [Full Text] [Related]  

  • 43. Anemia of uremia responsive to increased dialysis treatment.
    Lindholm DD; Pace RL; Russell HH
    Trans Am Soc Artif Intern Organs; 1969; 15():360-6. PubMed ID: 5791410
    [No Abstract]   [Full Text] [Related]  

  • 44. [Rosette E and active rosette E tests in the evaluation of cell-mediated immunity in uremic patients].
    Giacchino F; Giachino G; Giraudo G; Boero R; Basolo B; Bancale E; Nigra M; Piccoli GB; Piccoli G
    Arch Sci Med (Torino); 1982; 139(1):19-22. PubMed ID: 7103704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of different types of substitutive treatment on fibrinolytic potential of chronic uremic patients].
    Canavese C; Stratta P; Mangiarotti G; Triolo G; Bagnis C; Racca M; Vercellone A
    Minerva Nefrol; 1981; 28(3):339-43. PubMed ID: 7329613
    [No Abstract]   [Full Text] [Related]  

  • 46. [Study of hemostasis and coagulation in uremic patients during extra-corporeal dialysis].
    Praga C; Brancaccio D; Cortellaro M; Pisani E; Della Grazia ME
    Minerva Nefrol; 1966; 13(4):122-33. PubMed ID: 5995533
    [No Abstract]   [Full Text] [Related]  

  • 47. [The alpha-1-acid glycoprotein (alpha-1-ag) in serum of uremic patients in maintenance hemodialysis].
    Docci D; Cenciotti L; Turci F; Salvi G
    Quad Sclavo Diagn; 1982 Dec; 18(4):416-21. PubMed ID: 7186645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Changes in membrane sodium transport and arterial hypertension in uremic patients under dialysis].
    Quarello F; Boero R; Guarena C; Berto I; Colombo P; Beltrame G; Piccoli G
    Minerva Urol Nefrol; 1988; 40(3):207-10. PubMed ID: 2853454
    [No Abstract]   [Full Text] [Related]  

  • 49. [Analysis of blood digitalis levels in uremic patients in dialysis treatment].
    Cantù P; Limido A; Caretta E; Bianchi P
    Farmaco Prat; 1987 Aug; 42(8):205-8. PubMed ID: 3622755
    [No Abstract]   [Full Text] [Related]  

  • 50. Compartmental analysis of sodium dynamics in non-edematous, edematous and uremic patients.
    Kinouchi T
    Jpn Heart J; 1971 Sep; 12(5):415-35. PubMed ID: 5315442
    [No Abstract]   [Full Text] [Related]  

  • 51. Suppression of renin in diabetic patients under chronic dialysis treatment.
    Kaneda H; Matsumoto J; Haruyama T; Yoshikawa K; Takeuchi M; Murata T
    Tohoku J Exp Med; 1979 Feb; 127(2):169-75. PubMed ID: 760263
    [No Abstract]   [Full Text] [Related]  

  • 52. [Ganglioside therapy in uremic polyneuropathy].
    Krämer G; Süss W; Köhler H; Schneider B; Hopf HC
    Med Klin (Munich); 1988 Jan; 83(1):7-11, 40. PubMed ID: 3352557
    [No Abstract]   [Full Text] [Related]  

  • 53. [Exchangeable sodium, water spaces, blood renin and arterial pressure in a group of chronic uremics in periodic hemodialytic therapy, undergoing binephrectomy].
    Romagnoli GF; Borsatti A; Giongo A; Muolo A; Huber W; Galvani E; Guarnieri GF; Mioni G
    G Clin Med; 1969 Dec; 50(12):1197-206. PubMed ID: 5386468
    [No Abstract]   [Full Text] [Related]  

  • 54. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Behavior of organic sodium and blood pressure levels in uremic subjects undergoing continuous hemodilaytic treatment].
    Lamperi S; Sitia L; Bandiani G
    Minerva Nefrol; 1969; 16(6):407-12. PubMed ID: 5403803
    [No Abstract]   [Full Text] [Related]  

  • 56. [Importance of the sodium content of the dialytic fluid in periodic hemodialysis. Data on the behavior of arterial pressure, corporeal sodium pattern and the plasma renin activity in some hypertensive, chronic uremic patients treated with dialysis with a bath with varying sodium content].
    Romagnoli GF; Huber W; Di Landro D; Bertoli M; Antonello A; Cerutti M; Chini M
    Minerva Nefrol; 1975; 22(4-5):205-11. PubMed ID: 1207978
    [No Abstract]   [Full Text] [Related]  

  • 57. [Blood pressure values and organic content of sodium in the pre- and post-dialysis phases, evaluated in uremic patients exposed to continuous dialytic treatment].
    Lamperi S; Sitia L; Bandiani G
    Minerva Nefrol; 1969; 16(1):51-4. PubMed ID: 5768267
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.